Azetidine-substituted fluorescent compounds

US2019107534A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2019107534-A1
Application numberUS-201816211388-A
CountryUS
Kind codeA1
Filing dateDec 6, 2018
Priority dateApr 1, 2014
Publication dateApr 11, 2019
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The presently-disclosed subject matter includes azetidine-substituted fluorescent compounds, where the compounds may be used as probes, dyes, tags, and the like. The presently-disclosed subject matter also includes kits comprising the same as well as methods for using the same to detect a target substance.

First claim

Opening claim text (preview).

What is claimed is: 1 . A compound of the formula: wherein: each R is independently selected from halogen, H, CN, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), amine, NO 2 ,CHO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), PO 3 H 2 , SO 3 H, and alkyl, alkyl being optionally substituted with one or more heteroatoms independently selected from N, O, and S, halogen, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), amine, NO 2 , CHO, COO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), PO 3 H 2 , and/or SO 3 H; Q is selected from CR 2 , NR′, O, S, SiR 2 , and Se; R′ is independently selected from halogen, CN, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), amine, NO 2 , CHO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), PO 3 H 2 , SO 3 H, and alkyl, alkyl being optionally substituted with one or more heteroatoms independently selected from N, O, and S, halogen, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), amine, NO 2 , CHO, COO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), PO 3 H 2 , and/or SO 3 H; W is selected from C and N; X is selected from a lone pair of electrons, H, alkyl, aryl, halogen, CN, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), amine, NO 2 ,CHO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), PO 3 H 2 , and SO 3 H, X being optionally substituted with one or more heteroatoms independently selected from N, O, and S, halogen, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), amine, NO 2 , CHO, COO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), C(O)NR 2 , PO 3 H 2 , and/or SO 3 H; M is selected from CR 2 , C(O), SO 2 , and PO 2 ; L is selected from O, S, NR, and CN 2 , wherein optionally L and W, taken together with the atoms to which they are bonded, can form a substituted or unsubstituted 5-7 membered ring; U and V are independently selected from H, alkyl, halogen, CN, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), amine, NO 2 , CHO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), PO 3 H 2 , and SO 3 H, alkyl being optionally substituted with one or more heteroatoms independently selected from N, O, and S, halogen, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), amine, NO 2 , CHO, COO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), PO 3 H 2 , and/or SO 3 H, or wherein U and V, taken together with the atoms to which they are bonded, can form a substituted or unsubstituted 5-7 membered ring; Y is selected from CR 2 , C(O)NR 2 , NR, O, and S; and Z is selected from H, halogen, CN, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), amine, NO 2 , CHO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), PO 3 H 2 , SO 3 H, aryl, and alkyl, alkyl and aryl being optionally substituted with one or more heteroatoms independently selected from N, O, and S, halogen, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), amine, NO 2 , CHO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), PO 3 H 2 , and SO 3 H, or wherein Z and Y, taken together with the atoms to which they are bonded, can form a substituted or unsubstituted 5-7 membered ring.

Assignees

Inventors

Classifications

  • having one double bond between ring members or between a ring member and a non-ring member · CPC title

  • Oxazine dyes · CPC title

  • Dyes containing a substituent, which contains a silicium atom · CPC title

  • Spiro-condensed systems · CPC title

  • containing organic luminescent materials · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2019107534A1 cover?
The presently-disclosed subject matter includes azetidine-substituted fluorescent compounds, where the compounds may be used as probes, dyes, tags, and the like. The presently-disclosed subject matter also includes kits comprising the same as well as methods for using the same to detect a target substance.
Who is the assignee on this patent?
Hughes Howard Med Inst
What technology area does this patent fall under?
Primary CPC classification G01N33/52. Mapped technology areas include Physics.
When was this patent published?
Publication date Thu Apr 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).